Nexstim Email Formats

Medical Equipment Manufacturing • Helsinki, Uusimaa, Finland • 51-100 Employees

Nexstim Email Formats

Nexstim uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@nexstim.com), used 86.2% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@nexstim.com	86.2%
{first initial}.{last name}	j.doe@nexstim.com	13.8%

Key Contacts at Nexstim

Gustaf Järnefelt

R&D Director

Mark Cox

Director Of Business Development

Anna Honkanen

Director, Quality And Regulatory Affairs

Mark Cox

Director Of Business Development

Company overview

Headquarters	Elimäenkatu 9 B, Helsinki, FI-00510, FI
Phone number	+35892727170
Website	nexstim.com
NAICS	3391
SIC	382
Keywords	TMS, Transcranial Magnetic Stimulation, Brain Mapping, Ntms
Founded	2000
Employees	51-100
Socials

About Nexstim

Nexstim is a Finnish, globally operating medical technology company. Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain. SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain. In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on Nasdaq First North Growth Market Finland.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

Nexstim has 20 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Nexstim's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-07-18	14	$1,100,000
2024-07-27	16	$1,600,000

Funding Insights

$2,700,000

Total funding amount

$1,600,000

Most recent funding amount

Number of funding rounds

Nexstim Tech Stack

Discover the technologies and tools that power Nexstim's digital infrastructure, from frameworks to analytics platforms.

Emotion

Development

MUI

UI frameworks

Salesforce

CRM

Usercentrics

Cookie compliance

Salesforce Marketing Cloud Account Engagement

Marketing automation

jQuery

JavaScript libraries

LiteSpeed

Web servers

Google Tag Manager

Tag managers

HTTP/3

Miscellaneous

PHP

Programming languages

HSTS

Security

React

JavaScript frameworks

Frequently asked questions

Nexstim is located in Helsinki, Uusimaa, FI.

You can reach Nexstim at +35892727170.

Nexstim was founded in 2000, making it 26 years old. The company has established itself as a significant player in its industry over this time.

Nexstim has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Nexstim has raised a total of $2,700,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Nexstim

Gustaf Järnefelt

R&D Director

Mark Cox

Director Of Business Development

Anna Honkanen

Director, Quality And Regulatory Affairs

Mark Cox

Director Of Business Development

4.8